BACKGROUND: One of the novel and promising plasma markers for detection of tissue
injury is the family of 15 kDa cytoplasmic fatty acid-binding proteins of which various tissue …

The first account of the use of a biochemical marker in the study of myocardial injury was
published by La Due and colleagues in the journal Science in 1954. 85 They measured …

A label-free immunosensor based on electrochemical impedance spectroscopy has been
developed for the sensitive detection of a cardiac biomarker myoglobin (cMyo) …

Each year, a large number of patients are seen in the Emergency Department with
presentations necessitating investigation for possible acute myocardial infarction. Patients …

The MALDI-TOF spectra of peptides from the sera of normal and myocardial infarction
patients produced patterns that provided an accurate diagnostic of MI. In myocardial …

Fluorescence-based sensing is a significant technique used in prominent fields such as
fluorescence-activated cell sorting, DNA sequencing, high-throughput screening, and …

Universally, cardiovascular disease (CVD) is recognised as the prime cause of death with
estimates exceeding 20 million by 2015 due to heart disease and stroke. Facts regarding the …

Acute myocardial infarction (AMI) is the world's leading cause of mortality and morbidity.
Therefore, quick and reliable diagnostics of AMI is extremely critical. Compared to the …

Background: The effect of decreasing lab turnaround times on emergency department (ED)
efficiency can be estimated through system‐level simulation models and help identify …

Cardiac troponin (cTn) I and T are released from myocardial cells following necrosis, ie, cell
death. An accurate measure of cTn concentrations in a patient's blood following …